Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Oncogene
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
20 August 1998, Volume 17, Number 7, Pages 877-887
Table of contents    Previous  Abstract  Next   Article  PDF
Original article
Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a Protein kinase C-mediated pathway
A Cadoret1, S Baron-Delage1, F Bertrand1, M Kornprost1, A Groyer2, C Gespach3, J Capeau1 and G Cherqui1,a

1INSERM U.402, Laboratoire de Biologie Cellulaire, Faculté de Médecine Saint-Antoine, 27, rue Chaligny, 75571 Paris Cédex 12, France

2INSERM U.327, Faculté de Médecine Xavier Bichat, 16, rue Henri Huchard 75018 Paris, France

3INSERM U.482, Hôpital Saint-Antoine, 75571 Paris Cédex 12, France

aAuthor for correspondence

Abstract

We previously reported that ras and polyoma middle T (PyMT), a constitutive activator of the src proto-oncogene product, up-regulated Caco-2 cell proliferation along with protein kinase C (PKC) alpha expression and PKC activity. We aimed to investigate whether oncogene-induced up-regulation of Caco-2 cell proliferation involved stimulation of the autocrine IGF-II/IGF-I receptor (IGF1R) loop described in these cells and if so, to analyse the role of overexpressed and activated PKC. Compared with control vector transfected Caco-2 cells, ras- and PyMT-transfected cells exhibited increased expression of the 6.0 and 4.8 kb IGF-II transcripts. This was due to increased activity of the P3 and P4 promoters of the IGF-II gene which correlated with increased expression and DNA-binding activity of Sp1, a transcription factor interacting with several specific sites in P3 and P4 promoters. Oncogene-transfected cells displayed enhanced autocrine IGF-II production, which was fully responsible for the oncogene-induced increase in their proliferation since this increase was blunted by anti-human IGF-II and IGF1R (alphaIR3) antibodies. PKC mediated oncogene activation of the IGF-II gene presumably through action on Sp1 since (i) PKC activation by phorbol 12-myristate 13-acetate increased Sp1 expression, P3 and P4 activity and IGF-II mRNA in control but not in oncogene-transfected cells; and (ii) PKC inhibition by the PKC inhibitor Gö6976 reduced Sp1, P3 and P4 activity and IGF-II mRNA in all three cell lines. This is the first evidence that ras- and PyMT/src oncogenes up-regulate Caco-2 cell proliferation through a PKC-mediated pathway which stimulates IGF-II gene transcription and thereby increases autocrine IGF-II production. The mechanisms underlying IGF-II gene activation by PKC most probably involve action on Sp1.

Keywords

Ha-ras; polyoma middle T; IGF-II gene; PKC; Sp1; Caco-2 cells

Received 8 October 1997; revised 31 March 1998; accepted 31 March 1998
20 August 1998, Volume 17, Number 7, Pages 877-887
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 1998 Nature Publishing Group